150 related articles for article (PubMed ID: 35918537)
21. Mosaicism in von Hippel-Lindau disease with severe renal manifestations.
Wu P; Zhang N; Wang X; Li T; Ning X; Bu D; Gong K
Clin Genet; 2013 Dec; 84(6):581-4. PubMed ID: 23384228
[TBL] [Abstract][Full Text] [Related]
22. Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.
Yuan P; Sun Q; Liang H; Wang W; Li L; Wang Y; Deng H; Lai L; Chen X; Zhou X
Cancer Biol Ther; 2016 Jun; 17(6):599-603. PubMed ID: 27057652
[TBL] [Abstract][Full Text] [Related]
23. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
24. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
25. Whole-exome sequencing and immunohistochemistry findings in von Hippel-Lindau disease.
Guo X; Gao L; Hong X; Guo D; Di W; Wang X; Xu Z; Xing B
Mol Genet Genomic Med; 2019 Sep; 7(9):e880. PubMed ID: 31317677
[TBL] [Abstract][Full Text] [Related]
26. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
[TBL] [Abstract][Full Text] [Related]
27. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.
Shuin T; Yamasaki I; Tamura K; Okuda H; Furihata M; Ashida S
Jpn J Clin Oncol; 2006 Jun; 36(6):337-43. PubMed ID: 16818478
[TBL] [Abstract][Full Text] [Related]
28. Risk of new tumors in von Hippel-Lindau patients depends on age and genotype.
Binderup ML; Budtz-Jørgensen E; Bisgaard ML
Genet Med; 2016 Jan; 18(1):89-97. PubMed ID: 25834951
[TBL] [Abstract][Full Text] [Related]
29. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
30. Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects.
Shehata BM; Stockwell CA; Castellano-Sanchez AA; Setzer S; Schmotzer CL; Robinson H
Adv Anat Pathol; 2008 May; 15(3):165-71. PubMed ID: 18434768
[TBL] [Abstract][Full Text] [Related]
31. Evidence for genetic anticipation in vonHippel-Lindau syndrome.
Aronoff L; Malkin D; van Engelen K; Gallinger B; Wasserman J; Kim RH; Villani A; Meyn MS; Druker H
J Med Genet; 2018 Jun; 55(6):395-402. PubMed ID: 29437867
[TBL] [Abstract][Full Text] [Related]
32. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
[TBL] [Abstract][Full Text] [Related]
33. A genetic register for von Hippel-Lindau disease.
Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
[TBL] [Abstract][Full Text] [Related]
34. [Von Hippel-Lindau syndrome - a case report].
Figlus M; Kaczorowska B; Jaskólski DJ; Kępczyński Ł
Pol Merkur Lekarski; 2018 May; 44(263):248-252. PubMed ID: 29813043
[TBL] [Abstract][Full Text] [Related]
35. Two tests of peripheral blood by standard methods were negative for Von Hippel-Lindau mutations: A case report.
Deng B; Liu C
Asian J Surg; 2023 Sep; 46(9):4101-4102. PubMed ID: 37147258
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
[TBL] [Abstract][Full Text] [Related]
37. Characterization of VHL promoter variants in patients suspected of Von Hippel-Lindau disease.
Albanyan S; Giles RH; Gimeno EM; Silver J; Murphy J; Faghfoury H; Morel CF; Machado J; Kim RH
Eur J Med Genet; 2019 Mar; 62(3):177-181. PubMed ID: 30006056
[TBL] [Abstract][Full Text] [Related]
38. Surveillance in von Hippel-Lindau disease (vHL).
Poulsen ML; Budtz-Jørgensen E; Bisgaard ML
Clin Genet; 2010 Jan; 77(1):49-59. PubMed ID: 19863552
[TBL] [Abstract][Full Text] [Related]
39. von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome.
Binderup MLM
Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510814
[TBL] [Abstract][Full Text] [Related]
40. Manifestations of Von Hippel Lindau syndrome: a retrospective national review.
O' Brien FJ; Danapal M; Jairam S; Lalani AK; Cunningham J; Morrin M; McNally S; Donovan MG; Little D; Tuthill A; Conlon PJ
QJM; 2014 Apr; 107(4):291-6. PubMed ID: 24352051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
